Treatment of External Genital Warts with Condylox (Podofilox)
Podofilox 0.5% solution or gel (Condylox) is a first-line patient-applied treatment for external genital warts, applied twice daily for 3 days followed by 4 days of no therapy, for up to 4 cycles. 1
Application Protocol
Dosage and Administration:
Important Limitations:
Initial Treatment:
- If possible, healthcare provider should apply the initial treatment to:
- Demonstrate proper application technique
- Identify which warts should be treated 2
- If possible, healthcare provider should apply the initial treatment to:
Efficacy and Mechanism
Podofilox works as an antimitotic drug that results in destruction of warts through necrosis of visible wart tissue 2, 1, 3. Clinical studies demonstrate:
- Clearance rates of 45-88% of warts 1
- In controlled studies, podofilox cleared 74% of total wart count compared to 18% with placebo (p<0.001) 4
- In another study, mean number of warts per patient was reduced from 6.27 to 1.1, with 50% of patients completely cleared of warts at 10 weeks 5
Side Effects and Monitoring
Common Side Effects:
Monitoring:
Special Considerations
Contraindications:
Diagnosis:
- Confirm diagnosis before treatment, particularly to differentiate from squamous cell carcinoma
- Histopathologic confirmation should be obtained if there is any doubt 3
Recurrence:
Alternative Treatment Options
If podofilox is ineffective or contraindicated, consider these alternatives:
Other Patient-Applied Options:
Provider-Administered Options:
Treatment Selection Tips
- Podofilox is most effective for small, few warts on dry surfaces
- For warts on moist surfaces or intertriginous areas, TCA/BCA or imiquimod may be more effective
- For extensive warts, provider-administered cryotherapy or surgical removal may be preferred 1